tradingkey.logo

Annexon says enrollment of Phase 3 Archer II Trial expected to be completed in Q3 2025

ReutersJun 18, 2025 9:48 PM

- Annexon Inc ANNX.O:

  • ANNEXON INC - ENROLLMENT OF PHASE 3 ARCHER II TRIAL EXPECTED TO BE COMPLETED IN Q3 2025, WITH TOPLINE DATA EXPECTED IN SECOND HALF OF 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI